Abstract On July 29, 2021, the US Food and Drug Administration’s Oncology Center of Excellence convened Conversations on Cancer. This Conversation, the first ever by the US Food and Drug Administration, focused on Asian Americans and served as the platform for this Commentary. Panelists elaborated on topics ranging from heterogeneity in Asian American demographics to racism through a path to health equity and supplemented this Commentary with literature citations. Asian Americans are the fastest-growing US race group, yet data aggregation obscures distinctions and cancer disparities within the more than 24 million Asians living in the United States with harmful impacts on communities and patients, as illustrated by breast cancer survivor Susan Shinagawa’s patient-to-advocate journey. Bigotry against Asian Americans has been pervasive since the 19th century, but especially during the COVID-19 pandemic. Asian Americans are unique as the first US population to experience cancer as the leading cause of death. Asian Americans are disproportionately affected by cancers because of infectious origins and have the highest rates of lung cancer among never-smoking women. The infinitesimal proportion of the National Institutes of Health’s budget compared with experiencing the highest percentage increases of any US racial population more than 3 decades highlights the dearth of focused research among Asian Americans. Recognizing the heterogeneity of Asian Americans and that disaggregated data are critical for accurately characterizing distinct ethnic groups, focusing on the impact of racism and COVID-19 on cancer disparities, and focusing and prioritizing funding resources are necessary steps forward for achieving health equity for Asian Americans.

中文翻译：

---

制定亚裔美国人癌症健康公平之路：前进之路


摘要 2021年7月29日，美国食品和药物管理局肿瘤学卓越中心召开了癌症对话会。这次对话是美国食品和药物管理局首次以亚裔美国人为主题，并作为本评论的平台。小组成员详细阐述了从亚裔美国人人口统计的异质性到通过健康公平之路实现种族主义等主题，并通过文献引用补充了本评论。亚裔美国人是美国增长最快的种族群体，但数据汇总掩盖了居住在美国的超过 2400 万亚裔之间的差异和癌症差异，这对社区和患者产生了有害影响，乳腺癌幸存者苏珊·品川 (Susan Shinakawa) 的患者对亚裔患者的研究就表明了这一点。 ——倡导旅程。自 19 世纪以来，对亚裔美国人的偏见一直很普遍，尤其是在新冠肺炎 (COVID-19) 大流行期间。亚裔美国人是独一无二的，他们是第一批将癌症作为主要死因的美国人群。由于传染源，亚裔美国人患癌症的比例不成比例，并且在从不吸烟的女性中肺癌发病率最高。与三十多年来美国所有种族人口增长率最高的情况相比，美国国立卫生研究院预算所占的比例微乎其微，这突显了针对亚裔美国人的针对性研究的缺乏。认识到亚裔美国人的异质性以及分类数据对于准确描述不同种族群体的特征至关重要，关注种族主义和 COVID-19 对癌症差异的影响，并集中和优先考虑资金资源，是实现亚裔美国人健康公平的必要步骤。